Helicobacter pylori drug resistance: therapy changes and challenges

References

• Peek RM Jr., Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer. 2002 Jan;2(1):28–37. . PubMed PMID: 11902583.
   PubMed Web of Science ®Google Scholar
• Polk DB, Peek RM Jr. Helicobacter pylori: gastric cancer and beyond. Nat Rev Cancer. 2010 Jun;10(6):403–414. . PubMed PMID: 20495574; PubMed Central PMCID: PMCPMC2957472.
   PubMed Web of Science ®Google Scholar
• O’Connor A, O’Morain CA, Ford AC. Population screening and treatment of Helicobacter pylori infection. Nat Rev Gastroenterol Hepatol. 2017 Apr;14(4):230–240. . PubMed PMID: 28053340.
   PubMed Web of Science ®Google Scholar
• Plummer M, Franceschi S, Vignat J, et al. Global burden of gastric cancer attributable to Helicobacter pylori. Int J Cancer. 2015 Jan 15;136(2):487–490. PubMed PMID: 24889903.
   PubMed Web of Science ®Google Scholar
• Hooi JKY, Lai WY, Ng WK, et al. Global Prevalence of Helicobacter pylori Infection: systematic Review and Meta-Analysis. Gastroenterology. 2017 Aug;;153((2):):420–429. PubMed PMID: 28456631.
   PubMed Web of Science ®Google Scholar
• Burucoa C, Axon A. Epidemiology of Helicobacter pylori infection. Helicobacter. 2017 Sep;22(Suppl 1). PubMed PMID: 28891138. DOI:10.1111/hel.12403
   Google Scholar
• Fallone CA, Chiba N, Van Zanten SV, et al. The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults. Gastroenterology. 2016 Jul;151((1):):51–69 e14. PubMed PMID: 27102658.
   PubMed Web of Science ®Google Scholar
• Malfertheiner P, F M, O’Morain CA, et al. Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report. Gut. 2017 Jan;66(1):6–30. PubMed PMID: 27707777.
   PubMed Web of Science ®Google Scholar
• Chey WD, Leontiadis GI, Howden CW, et al. ACG Clinical Guideline: treatment of Helicobacter pylori Infection. Am J Gastroenterol. 2017 Feb;112(2):212–239. PubMed PMID: 28071659.
   PubMed Web of Science ®Google Scholar
• Bjorkman DJ, Steenblik M. Best Practice Recommendations for Diagnosis and Management of Helicobacter pylori-Synthesizing the Guidelines. Curr Treat Options Gastroenterol. 2017 Dec;15(4):648–659. 10.1007/s11938–017–0157–8. PubMed PMID: 28932965.
   PubMedGoogle Scholar
• Zagari RM, Rabitti S, Eusebi LH, et al. Treatment of Helicobacter pylori infection: A clinical practice update. Eur J Clin Invest. 2018 Jan;48(1). PubMed PMID: 29144559. DOI:10.1111/eci.12857.
   PubMed Web of Science ®Google Scholar
• Munoz-Gomez P, Jordan-Castro JA, Abanades-Tercero M, et al. Macrolide use in the previous years is associated with failure to eradicate Helicobacter pylori with clarithromycin-containing regimens. Helicobacter. 2018 Feb;23(1). PubMed PMID: 29178562. DOI:10.1111/hel.12452.
   PubMed Web of Science ®Google Scholar
• Smith SM, O’Morain C, McNamara D. Antimicrobial susceptibility testing for Helicobacter pylori in times of increasing antibiotic resistance. World J Gastroenterol. 2014 Aug 7;20(29):9912–9921. . PubMed PMID: 25110421; PubMed Central PMCID: PMCPMC4123372.
   PubMed Web of Science ®Google Scholar
• Arslan N, Yilmaz O, Demiray-Gurbuz E. Importance of antimicrobial susceptibility testing for the management of eradication in Helicobacter pylori infection. World J Gastroenterol. 2017 Apr 28;23(16):2854–2869. . PubMed PMID: 28522904; PubMed Central PMCID: PMCPMC5413781.
   PubMed Web of Science ®Google Scholar
• Hu Y, Zhang M, Lu B, et al. Helicobacter pylori and Antibiotic Resistance, A Continuing and Intractable Problem. Helicobacter. 2016 Oct;;21((5):):349–363. PubMed PMID: 26822340.
   PubMed Web of Science ®Google Scholar
• Piccolomini R, Di Bonaventura G, Catamo G, et al. Comparative evaluation of the E test, agar dilution, and broth microdilution for testing susceptibilities of Helicobacter pylori strains to 20 antimicrobial agents. J Clin Microbiol. 1997 Jul;35(7):1842–1846. PubMed PMID: 9196205; PubMed Central PMCID: PMCPMC229853.
   PubMed Web of Science ®Google Scholar
• CLSI. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria. 3rd ed. CLSI guideline M45. Wayne, PA: Clinical and Laboratory Standards Institute; 2015.
   Google Scholar
• EUCAST. European Committee on ANTIMICROBIAL SUSCEPTIBILITY TESTING. Breakpoint tables for interpretation of MICs and zone diameters. 2018. Available from: http://www.eucast.org/clinical_breakpoints Accessed 2018 Jun 22
   Google Scholar
• Hu Y, Zhu Y, Lu NH. Primary Antibiotic Resistance of Helicobacter pylori in China. Dig Dis Sci. 2017 May;62(5):1146–1154. 10.1007/s10620–017–4536–8. PubMed PMID: 28315035.
   PubMed Web of Science ®Google Scholar
• Gerrits MM, Van Vliet AH, Kuipers EJ, et al. Helicobacter pylori and antimicrobial resistance: molecular mechanisms and clinical implications. Lancet Infect Dis. 2006 Nov;;6((11):):699–709. PubMed PMID: 17067919.
   PubMed Web of Science ®Google Scholar
• Kuo YT, Liou JM, El-Omar EM, et al. Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2017 Oct;2(10):707–715. PubMed PMID: 28781119.
   PubMed Web of Science ®Google Scholar
• O’Connor A, Lamarque D, Gisbert JP, et al. Treatment of Helicobacter pylori infection 2017. Helicobacter. 2017;22Suppl 1doi:10.1111/hel.12410. Sep PubMed PMID: 28891137
   PubMedGoogle Scholar
• Hu Y, Zhu Y, Lu NH. Novel and Effective Therapeutic Regimens for Helicobacter pylori in an Era of Increasing Antibiotic Resistance. Front Cell Infect Microbiol. 2017;7:168. PubMed PMID: 28529929; PubMed Central PMCID: PMCPMC5418237.
   PubMed Web of Science ®Google Scholar
• Alba C, Blanco A, Alarcon T. Antibiotic resistance in Helicobacter pylori. Curr Opin Infect Dis. 2017 Oct;30(5):489–497. . PubMed PMID: 28704226
   PubMed Web of Science ®Google Scholar
• Macias-Garcia F, Llovo-Taboada J, Diaz-Lopez M, et al. High primary antibiotic resistance of Helicobacter Pylori strains isolated from dyspeptic patients: A prevalence cross-sectional study in Spain. Helicobacter. 2017 Dec;22(6). PubMed PMID: 28913872. DOI:10.1111/hel.12440.
   PubMed Web of Science ®Google Scholar
• Tan B, Yang JC, Young CL, et al. Helicobacter pylori Antimicrobial Susceptibility Testing-Guided Salvage Therapy in the USA: A Real Life Experience. Dig Dis Sci. 2018 Feb;63(2):437-445. PubMed PMID: 29264696. DOI:10.1007/s10620–017–4880-8.
   Web of Science ®Google Scholar
• Zerbetto De Palma G, Mendiondo N, Wonaga A, et al. Occurrence of mutations in the antimicrobial target genes related to levofloxacin, clarithromycin, and amoxicillin resistance in helicobacter pylori isolates from buenos aires city. Microb Drug Resist. 2017 Apr;23(3):351–358. PubMed PMID: 27391421; PubMed Central PMCID: PMCPMC5397209.
   PubMed Web of Science ®Google Scholar
• Angol DC, Ocama P, Ayazika Kirabo T, et al. helicobacter pylori from peptic ulcer patients in uganda is highly resistant to clarithromycin and fluoroquinolones: results of the genotype helicodr test directly applied on stool. Biomed Res Int. 2017;2017:5430723. PubMed PMID: 28555193; PubMed Central PMCID: PMCPMC5438841.
   PubMedGoogle Scholar
• Raaf N, Amhis W, Saoula H, et al. Prevalence, antibiotic resistance, and MLST typing of Helicobacter pylori in Algiers, Algeria. Helicobacter. 2017 Dec;22(6). PubMed PMID: 29035009. DOI:10.1111/hel.12446.
   PubMed Web of Science ®Google Scholar
• Dargiene G, Kupcinskas J, Jonaitis L, et al. Primary antibiotic resistance of Helicobacter pylori strains among adults and children in a tertiary referral centre in Lithuania. APMIS. 2018 Jan;126(1):21–28. PubMed PMID: 29131410.
   PubMed Web of Science ®Google Scholar
• Abadi ATB. Resistance to clarithromycin and gastroenterologist’s persistence roles in nomination for Helicobacter pylori as high priority pathogen by World Health Organization. World J Gastroenterol. 2017 Sep 21;23(35):6379–6384. . PubMed PMID: 29085187; PubMed Central PMCID: PMCPMC5643263.
   PubMed Web of Science ®Google Scholar
• Thung I, Aramin H, Vavinskaya V, et al. Review article: the global emergence of Helicobacter pylori antibiotic resistance. Aliment Pharmacol Ther. 2016 Feb;43(4):514–533. PubMed PMID: 26694080; PubMed Central PMCID: PMCPMC5064663.
   PubMed Web of Science ®Google Scholar
• Mascellino MT, Porowska B, De Angelis M, et al. Antibiotic susceptibility, heteroresistance, and updated treatment strategies in Helicobacter pylori infection. Drug Des Devel Ther. 2017;11::2209–2220. PubMed PMID: 28814829; PubMed Central PMCID: PMCPMC5546184.
   PubMed Web of Science ®Google Scholar
• Khoury J, Geffen Y, Shaul R, et al. Secondary antibiotic resistance of Helicobacter pylori isolates in Israeli children and adults. J Glob Antimicrob Resist. 2017 Sep;10:182–185. PubMed PMID: 28732784.
   PubMed Web of Science ®Google Scholar
• Kori M, Yahav J, Berdinstein R, et al. Primary and Secondary Antibiotic Resistance of Helicobacter pylori in Israeli Children and Adolescents. Isr Med Assoc J. 2017 Dec;19(12):747–750. PubMed PMID: 29235736.
   PubMed Web of Science ®Google Scholar
• Pastukh N, Peretz A, Brodsky D, et al. The antimicrobial susceptibility of Helicobacter pylori in strains isolated from children in Israel. J Glob Antimicrob Resist. 2017 Oct;12. PubMed PMID: 29033302. DOI:10.1016/j.jgar.2017.10.004.
   PubMed Web of Science ®Google Scholar
• Ruiter R, Wunderink HF, Veenendaal RA, et al. Helicobacter pylori resistance in the Netherlands: a growing problem? Neth J Med. 2017 Nov;75(9):394–398. PubMed PMID: 29219812.
   PubMed Web of Science ®Google Scholar
• Hays C, Burucoa C, Lehours P, et al. Molecular characterization of Helicobacter pylori resistance to rifamycins. Helicobacter. 2018 Feb;23(1). PubMed PMID: 29168600. DOI:10.1111/hel.12451.
   PubMed Web of Science ®Google Scholar
• Zamani M, Rahbar A, Shokri-Shirvani J. Resistance of Helicobacter pylori to furazolidone and levofloxacin: A viewpoint. World J Gastroenterol. 2017 Oct 07;23(37):6920–6922. PubMed PMID: 29085236; PubMed Central PMCID: PMCPMC5645626.
   PubMed Web of Science ®Google Scholar
• Mahmoudi S, Mamishi S, Banar M, et al. Antibiotic susceptibility of Helicobacter pylori strains isolated from Iranian children: high frequency of A2143G point mutation associated with clarithromycin resistance. J Glob Antimicrob Resist. 2017 Sep;10:131–135. PubMed PMID: 28720314
   PubMed Web of Science ®Google Scholar